3 RP1 (Anastrozole 1 mg)
Pill imprint 3 RP1 has been identified as Anastrozole 1 mg.
Anastrozole is used in the treatment of breast cancer; pubertal gynecomastia; mccune-albright syndrome; breast cancer, metastatic; endometrial cancer and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Anastrozole 1 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for 3 RP1 (Anastrozole 1 mg)
- Imprint:
-
3 RP1
- Strength:
- 1 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Aromatase inhibitors
Hormones/antineoplastics - Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Three Rivers Pharmaceuticals, LLC
- National Drug Code (NDC):
- 66435-0415
- Inactive Ingredients:
- lactose monohydrate
lactose anhydrous
sodium starch glycolate type A potato
microcrystalline cellulose
silicon dioxide
magnesium stearate
titanium dioxide
hypromellose
polyethylene glycol
| NDC Code | Manufacturer / Repackager |
|---|---|
| 42043-0180 | Karalex Pharma |
Note: Inactive ingredients may vary.
More resources
Anastrozole is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
